3 October 2018 Blog Post: Mandatory CURES Consultation in Effect October 2nd, 2018
With very little fanfare (somewhat unexpectedly so from my perspective), a new state mandate went into effect today for all medical and allied health professionals authorized to prescribe, order, administer, furnish or dispense controlled substances in California. All providers must (with some exceptions) check a patient’s prescription history in California’s Controlled Substance Utilization Review and Evaluation System – also known as CURES 2.0 – before prescribing a Schedule II-IV substance.
This requirement has gone into effect as the US healthcare system grapples with the ongoing opioid epidemic. To ensure proper prescribing and administering of controlled substances, the California Department of Justice therefore certified the CURES database for statewide use. In doing so, CURES 2.0 aids prescribers and dispensers in identifying fraudulent activity and is intended to reduce prescription drug abuse and diversion without affecting legitimate medical practice or patient care.
At Santa Monica Primary Care, we do not anticipate that this change will cause a significant impact for most of our patients. However, those that are currently taking any of the Schedule II-IV medications will qualify for additional office and/or telemedicine visits in order to fully comply with this new effort. These will be performed to assess ongoing effectiveness of the medication as part of a comprehensive treatment plan. Patients who are affected will be contacted on an individual basis with additional details.
𝗦𝗶𝗴𝗻 𝗨𝗽 𝗳𝗼𝗿 𝗢𝘂𝗿 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿
by submitting this form you indicate you have
read and agree to our Privacy Policy and Terms
of Use. Please contact us to for us for more
information.
No comment yet, add your voice below!